Re: Common Theme, OTC

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

virtvision

Rank: Vice President [?]

Points: 2410 [?]

Votes: 66 Score: 3.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Common Theme, OTC

in response to

Common Theme, OTC

emit

posted on Sep 20, 2008 08:20PM

I've read much talk regarding the possibilities of AVOT being IPO'd in the future and PTSC reaping the rewards. In the current toxic financial environment, the liklihood of an AVOT IPO or for that matter ANY IPO is nill. The credit markets are near frozen and the last thing any investor is looking at, is risking any money on a new issue (IPO). Investors are in a severe capital squeeze and are much more concerned about capital preservation than capital appreciation.

Furthermore, the technology involved with AVOT has not been proven in the marketplace outside of recent small area testing. The business model has not been validated. While the technology looks promising, product roll out to a large consumer marketplace is way down the line IMO, 2010 if not later. This is not the heady 2000 Internet IPO times when I was looking for my own "Angel" investor(s).

However, it would not surprise me for AVOT to attract a deep pocket investor to invest in the technology and AVOT in particular IMO. In fact, I think it is highly likely sometime in 2009.